Researchers were also able to artificially increase the levels of the molecule, irisin, in the blood to activate genes involved in learning and memory.
The findings may be useful for designing drugs that utilise this exercise-induced molecule to guard against neurodegenerative diseases and improve cognition in the ageing population.
While it's known that exercise can boost cognitive function and lessen symptoms of neurological diseases like depression, stroke, and Alzheimer's disease, the mechanisms underlying these effects are unclear.
One important player is thought to be a growth factor named brain-derived neurotrophic factor (BDNF).
On the other hand, mice genetically altered to have low irisin levels in the brain had reduced levels of BDNF.
The team also found that raising levels of irisin in the circulation caused the molecule to cross the blood brain barrier, where it increased expression of BDNF and activated genes involved in cognition.
"Our results indicate that FNDC5/irisin has the ability control a very important neuroprotective pathway in the brain," said Spiegelman.
The study was published in the Cell Press journal Cell Metabolism.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
